Deutsche Bank’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $68.9M | Buy |
983,450
+173,197
| +21% | +$8.96M | 0.02% | 586 |
|
|
2026
Q1 | $41.2M | Sell |
810,253
-309,838
| -28% | -$14.5M | 0.01% | 678 |
|
|
2025
Q4 | $33M | Sell |
1,120,091
-142,796
| -11% | -$3.88M | 0.01% | 753 |
|
|
2025
Q3 | $32.6M | Buy |
1,262,887
+63,654
| +5% | +$1.78M | 0.01% | 727 |
|
|
2025
Q2 | $33.1M | Sell |
1,199,233
-538,132
| -31% | -$14.2M | 0.01% | 691 |
|
|
2025
Q1 | $49.3M | Sell |
1,737,365
-156,710
| -8% | -$5.56M | 0.02% | 619 |
|
|
2024
Q4 | $78.8M | Buy |
1,894,075
+669,614
| +55% | +$32M | 0.03% | 525 |
|
|
2024
Q3 | $81.8M | Buy |
1,224,461
+180,070
| +17% | +$16.5M | 0.03% | 468 |
|
|
2024
Q2 | $124M | Buy |
1,044,391
+72,189
| +7% | +$9.14M | 0.06% | 305 |
|
|
2024
Q1 | $104M | Sell |
972,202
-62,908
| -6% | -$6.34M | 0.05% | 347 |
|
|
2023
Q4 | $103M | Buy |
1,035,110
+272,868
| +36% | +$23M | 0.05% | 350 |
|
|
2023
Q3 | $78.7M | Sell |
762,242
-557,972
| -42% | -$62.2M | 0.05% | 353 |
|
|
2023
Q2 | $160M | Sell |
1,320,214
-490,549
| -27% | -$65.4M | 0.09% | 225 |
|
|
2023
Q1 | $278M | Sell |
1,810,763
-23,416
| -1% | -$3.86M | 0.15% | 143 |
|
|
2022
Q4 | $329M | Sell |
1,834,179
-439,435
| -19% | -$71.9M | 0.19% | 120 |
|
|
2022
Q3 | $269M | Buy |
2,273,614
+256,121
| +13% | +$38.9M | 0.16% | 130 |
|
|
2022
Q2 | $288M | Buy |
2,017,493
+212,432
| +12% | +$30.4M | 0.16% | 141 |
|
|
2022
Q1 | $311M | Buy |
1,805,061
+875,012
| +94% | +$147M | 0.15% | 144 |
|
|
2021
Q4 | $236M | Sell |
930,049
-154,878
| -14% | -$45.3M | 0.11% | 181 |
|
|
2021
Q3 | $418M | Buy |
1,084,927
+352,741
| +48% | +$130M | 0.2% | 115 |
|
|
2021
Q2 | $172M | Buy |
732,186
+186,927
| +34% | +$33.4M | 0.08% | 241 |
|
|
2021
Q1 | $71.4M | Sell |
545,259
-17,611
| -3% | -$2.55M | 0.04% | 456 |
|
|
2020
Q4 | $58.8M | Buy |
562,870
+159,647
| +40% | +$16.2M | 0.04% | 452 |
|
|
2020
Q3 | $28.5M | Buy |
403,223
+108,472
| +37% | +$7.56M | 0.02% | 605 |
|
|
2020
Q2 | $18.9M | Buy |
294,751
+171,954
| +140% | +$9.42M | 0.01% | 709 |
|
|
2020
Q1 | $3.68M | Sell |
122,797
-208,327
| -63% | -$4.79M | ﹤0.01% | 1414 |
|
|
2019
Q4 | $6.47M | Buy |
331,124
+322,004
| +3,531% | +$5.71M | ﹤0.01% | 1303 |
|
|
2019
Q3 | $144K | Sell |
9,120
-419,239
| -98% | -$6.19M | ﹤0.01% | 3379 |
|
|
2019
Q2 | $6.27M | Buy |
428,359
+406,395
| +1,850% | +$8.73M | ﹤0.01% | 1657 |
|
|
2019
Q1 | $446K | Buy |
+21,964
| New | +$408K | ﹤0.01% | 3525 |
|
Other funds holding MRNA
TP
Deutsche Bank's MRNA Position: Q2 2026 in Review
Deutsche Bank increased its Moderna (MRNA) stake by 21% in Q2 2026, buying an estimated $8.96M and bringing the position to 983,450 shares worth $68.9M. The position accounts for 0.02% of the portfolio, ranked #586.
Deutsche Bank first reported a position in MRNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $418M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Deutsche Bank held 983,450 shares of Moderna worth $68.9M as of Q2 2026.
- Deutsche Bank bought 173,197 Moderna shares in Q2 2026, an estimated $8.96M.
- Moderna made up 0.02% of Deutsche Bank's portfolio in Q2 2026, its #586 holding.
- Deutsche Bank first reported a position in Moderna in Q1 2019 and has held it in 30 quarters since.
- Deutsche Bank's Moderna position peaked at $418M in Q3 2021.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.